Catalyst Pharmaceuticals (NASDAQ:CPRX) reported its Q4 earnings results on Wednesday, March 16, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Catalyst Pharmaceuticals missed estimated earnings by 25.0%, reporting an EPS of $0.09 versus an estimate of $0.12.
Revenue was up $7.29 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 4.54% increase in the share price the next day.
Here's a look at Catalyst Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.1 | 0.09 | 0.09 | 0.09 |
| EPS Actual | 0.1 | 0.11 | 0.07 | 0.11 |
| Revenue Estimate | 34.59M | 31.51M | 32.10M | 30.35M |
| Revenue Actual | 35.95M | 36.37M | 30.20M | 31.02M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
